Deborah Ann Miller sold $950K of Nuvalent (NUVL)

Executed Jan 2, disclosed Jan 5, 3 days later.

Value, as filed

$950K

9,460 sh across 2 lots

Executed

Jan 2

the trade date, as filed

Disclosed

Jan 5

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Deborah Ann Miller Chief Legal Officer profile →

Deborah Ann Miller (Chief Legal Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Nuvalent Inc (NUVL). The largest single filing was $2.5M of NUVL (28,000 sh across 4 lots, as filed), executed Oct 15 2025.

The name

NUVL

Nuvalent Inc NUVL · Healthcare · 94 filings in 24 months ticker →

Healthcare · Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Deborah Ann Miller in NUVL

NUVLSALE Nuvalent Inc $496K
4,600 sh across 3 lots
Exec May 28
Filed Jun 1 · 5:30 PM ET NUVLSALE Nuvalent Inc $546K
5,500 sh across 2 lots
Exec Apr 30
Filed May 1 · 5:30 PM ET NUVLSALE Nuvalent Inc $451K
4,560 sh across 2 lots
Exec Mar 26
Filed Mar 30 · 5:30 PM ET NUVLSALE Nuvalent Inc $546K
5,300 sh across 2 lots
Exec Feb 26
Filed Mar 2 · 5:30 PM ET NUVLSALE Nuvalent Inc $1.6M
14,300 sh × $110.16
Exec Jan 22
Filed Jan 23 · 5:30 PM ET NUVLSALE Nuvalent Inc $540K
5,546 sh across 4 lots
Exec Jan 5
Filed Jan 7 · 5:30 PM ET NUVLSALE Nuvalent Inc $2.5M
23,592 sh across 2 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc $2.1M
20,000 sh across 5 lots
Exec Oct 30 2025
Filed Oct 31 2025 · 5:30 PM ET